Mitapivat Sulfate is used to treat pyruvate kinase deficiency (PKD), a rare genetic disorder that causes chronic hemolytic anemia. It works by activating the pyruvate kinase enzyme in red blood cells, improving their energy production and lifespan. Mitapivat is also being studied for use in thalassemia and sickle cell disease. It is grouped under the following drug class(es): Sickle cell agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pyrukynd and Mitapivat hemisulfate sesquihydrate. Its PubChem CID is 134693700.
Mitapivat sulfate
| CAS No | 2151847-10-6 |
|---|---|
| Molecular Formula | C48H60N8O13S3 |
| Molecular Weight | 1053.20 g/mol |
| Synonyms | bis(N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide);sulfuric acid;trihydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mitapivat Sulfate is used to treat pyruvate kinase deficiency (PKD), a rare genetic disorder that causes chronic hemolytic anemia. It works by activating the pyruvate kinase enzyme in red blood cells, improving their energy production and lifespan.
The listed CAS number is 2151847-10-6.
The listed molecular formula is C48H60N8O13S3.
The listed molecular weight is 1053.20 g/mol.
bis(N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide);sulfuric acid;trihydrate.
The source lists Pyrukynd and Mitapivat hemisulfate sesquihydrate.